NASDAQ:ALQA - Alliqua Biomedical Stock Price, Price Target & More Sign in or create an account to add this stock to your watchlist. Get Started $2.11 -0.05 (-2.31 %) (As of 07/17/2018 08:00 AM ET)Previous Close$2.16Today's Range$2.05 - $2.1652-Week Range$1.58 - $4.60Volume12,300 shsAverage Volume21,601 shsMarket Capitalization$10.81 millionP/E Ratio-0.33Dividend YieldN/ABeta0.93 Company ProfileFinancialsAnalyst RatingsEarnings HistoryInsider TradesHeadlinesOptions ChainSEC FilingsSocial MediaChart Share on FacebookShare on TwitterShare on LinkedInShare on RedditShare on StocktwitsPrint this articleShare by Email Alliqua BioMedical, Inc., a regenerative technologies company, commercializes regenerative medical products that assist the body in the repair or replacement of soft tissue. The company markets MIST Ultrasound Healing Therapy, a painless noncontact low-frequency ultrasound to promote healing; and Biovance Amniotic Membrane Allograft and Interfyl Human Connective Tissue Matrix, which are human biologic regenerative technologies. It also provides contract manufacturing services, including the development, manufacture, and marketing of high water content, electron beam cross-linked, and aqueous polymer hydrogels or gels used in wound care, medical diagnostics, transdermal drug delivery, and cosmetics. The company is headquartered in Yardley, Pennsylvania. Receive ALQA News and Ratings via Email Sign-up to receive the latest news and ratings for ALQA and its competitors with MarketBeat's FREE daily newsletter. Industry, Sector and Symbol Stock Exchange NASDAQ Industry Surgical & medical instruments Sub-IndustryN/A SectorMedical SymbolNASDAQ:ALQA CUSIPN/A Webwww.alliqua.com Phone215-702-8550 Debt Debt-to-Equity RatioN/A Current Ratio0.36 Quick Ratio0.28 Price-To-Earnings Trailing P/E Ratio-0.33 Forward P/E Ratio0.41 P/E GrowthN/A Sales & Book Value Annual Sales$19.57 million Price / Sales0.54 Cash FlowN/A Price / CashN/A Book Value$3.14 per share Price / Book0.67 Profitability EPS (Most Recent Fiscal Year)($6.49) Net Income$-25,700,000.00 Net Margins-114.41% Return on Equity-122.50% Return on Assets-63.67% Miscellaneous Employees60 Outstanding Shares5,010,000Market Cap$10.81 Alliqua Biomedical (NASDAQ:ALQA) Frequently Asked Questions What is Alliqua Biomedical's stock symbol? Alliqua Biomedical trades on the NASDAQ under the ticker symbol "ALQA." When did Alliqua Biomedical's stock split? How did Alliqua Biomedical's stock split work? Alliqua Biomedical's stock reverse split on the morning of Friday, October 6th 2017. The 1-10 reverse split was announced on Thursday, October 5th 2017. The number of shares owned by shareholders was adjusted after the market closes on Thursday, October 5th 2017. An investor that had 100 shares of Alliqua Biomedical stock prior to the reverse split would have 10 shares after the split. How were Alliqua Biomedical's earnings last quarter? Alliqua Biomedical Inc (NASDAQ:ALQA) announced its earnings results on Tuesday, August, 9th. The company reported $0.50 earnings per share for the quarter, topping the consensus estimate of ($2.70) by $3.20. The business earned $5.50 million during the quarter, compared to analysts' expectations of $5.38 million. Alliqua Biomedical had a negative return on equity of 122.50% and a negative net margin of 114.41%. View Alliqua Biomedical's Earnings History. What price target have analysts set for ALQA? 1 brokerages have issued 12-month price objectives for Alliqua Biomedical's stock. Their predictions range from $2.80 to $2.80. On average, they expect Alliqua Biomedical's stock price to reach $2.80 in the next year. This suggests a possible upside of 32.7% from the stock's current price. View Analyst Ratings for Alliqua Biomedical. What is the consensus analysts' recommendation for Alliqua Biomedical? 1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Alliqua Biomedical in the last year. There are currently 1 hold rating for the stock, resulting in a consensus recommendation of "Hold." Who are some of Alliqua Biomedical's key competitors? Some companies that are related to Alliqua Biomedical include Nephros (NEPH), Valeritas (VLRX), CELLECT BIOTECH/S (APOP), Obalon Therapeutics (OBLN), Presbia (LENS), Hancock Jaffe Laboratories (HJLI), Lianluo Smart (LLIT), AIT Therapeutics (AITB), Pro-Dex (PDEX), Interpace Diagnostics Group (IDXG), PAVmed (PAVM), DarioHealth (DRIO), Biostage (BSTG), Cytocore common stock (MDIT) and STRATA Skin Sciences (SSKN). Who are Alliqua Biomedical's key executives? Alliqua Biomedical's management team includes the folowing people: Mr. David Ian Johnson, Pres, CEO & Director (Age 60)Mr. Joseph M. Warusz, CFO, Treasurer & Sec. (Age 62)Dr. Phillip D. Forman M.D., DPM, Exec. VP of Clinical Affairs (Age 59)Mr. Gregory Robb, VP of Operations Has Alliqua Biomedical been receiving favorable news coverage? News coverage about ALQA stock has trended somewhat positive recently, Accern Sentiment Analysis reports. The research group ranks the sentiment of press coverage by reviewing more than 20 million blog and news sources. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores nearest to one being the most favorable. Alliqua Biomedical earned a media sentiment score of 0.21 on Accern's scale. They also assigned news coverage about the company an impact score of 46.14 out of 100, indicating that recent press coverage is somewhat unlikely to have an impact on the stock's share price in the next few days. How do I buy shares of Alliqua Biomedical? Shares of ALQA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab. What is Alliqua Biomedical's stock price today? One share of ALQA stock can currently be purchased for approximately $2.11. How big of a company is Alliqua Biomedical? Alliqua Biomedical has a market capitalization of $10.81 million and generates $19.57 million in revenue each year. The company earns $-25,700,000.00 in net income (profit) each year or ($6.49) on an earnings per share basis. Alliqua Biomedical employs 60 workers across the globe. How can I contact Alliqua Biomedical? Alliqua Biomedical's mailing address is 2150 CABOT BLVD WEST SUITE B, LANGHORNE PA, 19047. The company can be reached via phone at 215-702-8550 or via email at [email protected] MarketBeat Community Rating for Alliqua Biomedical (NASDAQ ALQA)Community Ranking: 3.2 out of 5 ( )Outperform Votes: 247 (Vote Outperform)Underperform Votes: 145 (Vote Underperform)Total Votes: 392MarketBeat's community ratings are surveys of what our community members think about Alliqua Biomedical and other stocks. Vote "Outperform" if you believe ALQA will outperform the S&P 500 over the long term. Vote "Underperform" if you believe ALQA will underperform the S&P 500 over the long term. You may vote once every thirty days. This page was last updated on 7/17/2018 by MarketBeat.com StaffFeatured Article: Should I follow buy, hold and sell recommendations?